undamentalytics Newsletter
Sign in

Penumbra Inc revenue

Penumbra Inc's revenue was $1.40bn in fiscal 2025, up 17.5% on the year before. Since fiscal 2013 ($88.8m) it has grown at a compound 25.9% a year. Over the last twelve months it was $1.56bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue891261862633344455475607488471,0591,1951,4041,560
Growth on the year before—+41.3%+48.3%+41.5%+26.8%+33.3%+23.0%+2.4%+33.4%+13.3%+25.0%+12.9%+17.5%—
Gross profit58831241712172933723384755356837559421,061
Gross margin65.1%66.0%66.7%64.9%65.1%65.7%68.0%60.3%63.6%63.2%64.5%63.2%67.1%68.0%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Thrombectomy $948M 67.5% ▲ 16.2%
Embolization $456M 32.5% ▲ 20.2%
Geography
Region Revenue Share YoY
United States $1.1B 77.8% ▲ 21.0%
Outside the US $312M 22.2% ▲ 6.6%

From Penumbra Inc's 10-K filed February 25, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Penumbra Inc $1.56bn 17.0% 16.2%
Merit Medical Systems Inc $1.61bn 9.1% 9.5%
Integra Lifesciences Holdings Corp $1.66bn 0.8% 2.4%
Haemonetics Corp $1.35bn 0.4% 3.5%
Stevanato Group S.p.a. $1.34bn 12.3% —
Integer Holdings Corp $1.83bn -0.3% 6.7%

Compare with peers

Head to head: MMSI vs PENIART vs PENHAE vs PENPEN vs STVN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Penumbra Inc's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Penumbra Inc.